We are live on ! Find out more
PTJ

Paul Tudor Jones Tudor Investment Corp

AUM $71.9B
1-Year Est. Return 42.37%
 

Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.

This Fund
S&P 500
This Quarter Est. Return
+6.24%
1 Year Est. Return
+42.37%
3 Year Est. Return
+108.76%
5 Year Est. Return
+114.43%
10 Year Est. Return
+640.77%
AUM
$3.92B
AUM Growth
+$638M
Cap. Flow
+$500M
Cap. Flow %
12.76%
Top 10 Hldgs %
55.08%
Holding
1,387
New
390
Increased
359
Reduced
286
Closed
329

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 8.7%
2 Industrials 7.54%
3 Technology 6.47%
4 Communication Services 6.38%
5 Healthcare 4.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBRG
1051
DELISTED
Bravo Brio Restaurant Group Inc.
BBRG
$36K ﹤0.01%
15,817
ARAV
1052
DELISTED
Aravive, Inc. Common Stock
ARAV
$34K ﹤0.01%
2,333
+250
+12% +$25.2K
ROSEW
1053
CALL
DELISTED
Rosehill Resources Inc.
ROSEW
$25K ﹤0.01%
25,000
HHS icon
1054
Harte-Hanks
HHS
$27.4M
$23K ﹤0.01%
2,177
NOG icon
1055
Northern Oil and Gas
NOG
$2.91B
$19K ﹤0.01%
2,143
-22
-1% -$225
NAVB
1056
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$19K ﹤0.01%
2,327
GEN
1057
DELISTED
Genesis Healthcare, Inc.
GEN
$16K ﹤0.01%
13,742
AAOI icon
1058
Applied Optoelectronics
AAOI
$10.6B
-8,889
Closed -$549K
ABBV icon
1059
AbbVie
ABBV
$468B
-15,220
Closed -$1.1M
ACAD icon
1060
Acadia Pharmaceuticals
ACAD
$5.08B
-16,847
Closed -$470K
ACTG icon
1061
Acacia Research
ACTG
$440M
-43,624
Closed -$179K
ADBE icon
1062
Adobe
ADBE
$109B
-10,325
Closed -$1.46M
ADC icon
1063
Agree Realty
ADC
$9.19B
-17,203
Closed -$789K
ADSK icon
1064
Autodesk
ADSK
$53.6B
-23,363
Closed -$2.35M
AIN icon
1065
Albany International
AIN
$1.68B
-4,315
Closed -$230K
AKBA icon
1066
Akebia Therapeutics
AKBA
$251M
-12,155
Closed -$175K
ALB icon
1067
Albemarle
ALB
$16.9B
-8,754
Closed -$924K
ALNT icon
1068
Allient
ALNT
$1.63B
-11,427
Closed -$207K
AMBA icon
1069
Ambarella
AMBA
$3.23B
-11,956
Closed -$580K
AME icon
1070
Ametek
AME
$54.9B
-13,284
Closed -$805K
AMKR icon
1071
Amkor Technology
AMKR
$12.5B
-26,746
Closed -$261K
APLE icon
1072
Apple Hospitality REIT
APLE
$3.94B
-33,646
Closed -$630K
ARCC icon
1073
Ares Capital
ARCC
$14.3B
-53,460
Closed -$876K
ASTE icon
1074
Astec Industries
ASTE
$1B
-5,715
Closed -$317K
ATEN icon
1075
A10 Networks
ATEN
$1.9B
-14,925
Closed -$126K

Similar funds

Paul Tudor Jones's Q3 2017 Portfolio in Review

As of Q3 2017, Paul Tudor Jones held 1,387 positions worth $3.92B, up 19% from $3.28B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Paul Tudor Jones deployed $500M of net new capital in Q3 2017, opening 390 new positions and adding to 359 existing holdings. Its largest new stake was Rockwell Collins: 293,445 shares worth $38.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 8.7% of assets, down from 11% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $98.5M trimmed.

  • Paul Tudor Jones's largest Q3 2017 buy was Rockwell Collins: 293,445 shares worth $38.4M.
  • Paul Tudor Jones added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $74.1M increase.
  • Paul Tudor Jones's biggest Q3 2017 reduction was Alphabet (Google) Class A, cutting an estimated $98.5M.
  • Paul Tudor Jones fully exited Meta Platforms (Facebook) in Q3 2017, selling an estimated $127M.
  • Paul Tudor Jones's ten largest holdings make up 55% of its $3.92B portfolio in Q3 2017.
  • Paul Tudor Jones opened 390 new positions and closed 329 in Q3 2017.
  • Paul Tudor Jones's portfolio value rose 19% quarter-over-quarter to $3.92B.

Based on Tudor Investment Corp's 13F filing for Q3 2017, filed 14 Nov 2017.